Upload

Loading...

This video is private.

If the owner of this video has granted you access, please sign in.

Watch Queue

TV Queue

Watch QueueTV Queue

    Loading...

Watch Queue
TV Queue
__count__/__total__

All Comments

Comments are disabled for this video.
  1. 113

    Yoseline's story -- USA

  2. 114

    Complex realities of global healthcare

  3. 115

    Novartis CEO Joe Jimenez: What do you tell a team that has failed?

  4. 116

    Each Voice Counts - The Experts

  5. 117

    The voice of advanced breast cancer patients on The Balancing Act® show

  6. 118

    The Next Generation Scientist 2012

  7. 119

    Novartis CEO Joe Jimenez: The best advice I ever got

  8. 120

    Each Voice Counts - The Family

  9. 121

    Periodic fever syndromes

  10. 122

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  11. 123

    A lifelong challenge: periodic fever syndromes

  12. 124

    Connections

  13. 125

    Each Voice Counts - The Women: Part 1

  14. 126

    Each Voice Counts - The Women: Part 2

  15. 127

    Unanswered questions about living with advanced breast cancer

  16. 128

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  17. 129

    Novartis International Biotechnology Leadership Camp 2012

  18. 130

    Journey of Chronic Myeloid Leukemia (CML)

  19. 131

    A look at the past decade in GIST: Chapter 6

  20. 132

    A look at the past decade in GIST: Chapter 5

  21. 133

    A look at the past decade in GIST: Chapter 4

  22. 134

    Vision loss due to Retinal Vein Occlusion (RVO)

  23. 135

    Vision loss due to Diabetic Macular Edema (DME)

  24. 136

    Vision loss due to wet age-related macular degeneration (wet AMD)

  25. 137

    A look at the past decade in GIST: Chapter 3

  26. 138

    Building the next generation of scientists

  27. 139

    A look at the past decade in GIST: Chapter 2

  28. 140

    A look at the past decade in GIST: Chapter 1

  29. 141

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  30. 142

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  31. 143

    Advanced breast cancer 101

  32. 144

    The mTOR pathway in ER+ advanced breast cancer

  33. 145

    Life in a Circle

  34. 146

    Understanding advanced breast cancer

  35. 147

    A Gift for Living

  36. 148

    The Villages Miles Away

  37. 149

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  38. 150

    Could your dog or cat be suffering from an allergy?

  39. 151

    Innovating to help eliminate malaria

  40. 152

    Malaria milestone video message

  41. 153

    Leo and Kya, friends against malaria

  42. 154

    The need for progress: what if?

  43. 155

    The myelofibrosis educational journey

  44. 156

    Understanding the progression of myelofibrosis

  45. 157

    Understanding the management of myelofibrosis

  46. 158

    The myelofibrosis disease burden

  47. 159

    The disease pathway associated with myelofibrosis

  48. 160

    New research developments in myelofibrosis

  49. 161

    Delivery of child-friendly antimalarial hits the 100 million mark

  50. 162

    Treating India's Leprosy patients

  51. 163

    Treating leprosy, caring for patients

  52. 164

    "SMS for Life" is expanding

  53. 165

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  54. 166

    Critical issues facing the advanced breast cancer patient community

  55. 167

    Advice to newly diagnosed advanced breast cancer patients

  56. 168

    Insight into the advanced breast cancer patient journey

  57. 169

    Pioneering an innovative social business model to fight malaria

  58. 170

    New media: drivers of democratization and development?

  59. 171

    What is it like living with myelofibrosis (MF)?

  60. 172

    What is the prognosis of myelofibrosis (MF)?

  61. 173

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  62. 174

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  63. 175

    What is myelofibrosis (MF)?

  64. 176

    How is the patient journey for advanced breast cancer patients different?

  65. 177

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  66. 178

    What is progression free survival and why is it important?

  67. 179

    What guidance do you give patients and family coping with advanced breast cancer?

  68. 180

    What insights can you share with newly diagnosed patients?

  69. 181

    Molecular pathways:The future of research at NIBR

  70. 182

    The importance of organ donation

  71. 183

    Novartis BioCamp 2011 (German)

  72. 184

    Novartis BioCamp 2011 (French)

  73. 185

    How is research in advanced breast cancer evolving?

  74. 186

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  75. 187

    What can a patient expect if diagnosed with advanced breast cancer?

  76. 188

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  77. 189

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  78. 190

    How does the advanced breast cancer treatment journey differ for patients?

  79. 191

    Novartis Be Healthy

  80. 192

    Novartis BioCamp 2011

  81. 193

    A sign from above

  82. 194

    Charlie

  83. 195

    Happy endings

  84. 196

    Herpes #1

  85. 197

    Herpes it's black and white

  86. 198

    Herpes the Ninja virus

  87. 199

    Magical elves with HSV

  88. 200

    Open happiness

  89. 201

    Play it smart

  90. 202

    Quarantine

  91. 203

    Strings

  92. 204

    Ah! Real herpes

  93. 205

    Down there

  94. 206

    Don't let herpes put you off

  95. 207

    Arogya Parivar: A social business model to improve health in rural India

  96. 208

    Living with multiple myeloma

  97. 209

    What are the symptoms of myelofibrosis (MF)?

  98. 210

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  99. 211

    Animals & Research: Think how far we've come

Loading...
Working...
to add this to Watch Later

Add to